Abstract:Objective The cannabinoid cannabidiol has established antiseizure effects in drug‐resistant epilepsies such as Dravet syndrome and Lennox–Gastaut syndrome. Amorfrutin 2, honokiol, and magnolol are structurally similar to cannabinoids (cannabis‐like drugs) but derive from non‐cannabis plants. We aimed to study the antiseizure potential of these compounds in various mouse seizure models. In addition, we aimed to characterize their molecular pharmacology at cannabinoid CB1 and CB2 receptors and at T‐type calcium channels, which are known targets of the cannabinoids. Methods Brain and plasma pharmacokinetic profiles were determined. Antiseizure activity was assessed against hyperthermia‐induced seizures in a Scn1a+/− mouse model of Dravet syndrome. We then elaborated on the most promising compounds in the maximal electroshock (MES) test in mice and the Gabrb3+/D120N mouse model of Lennox–Gastaut syndrome. Fluorescence‐based assays were used to examine modulatory activity at cannabinoid CB1 and CB2 receptors and T‐type calcium channel subtypes CaV3.1, CaV3.2, and CaV3.3 overexpressed in mammalian cells. Automated patch‐clamp electrophysiology was then used to confirm inhibitory activity on CaV3.1, CaV3.2, and CaV3.3 channels. Results Magnolol and honokiol had high brain‐to‐plasma ratios (3.55 and 7.56, respectively), unlike amorfrutin 2 (0.06). Amorfrutin 2 and magnolol but not honokiol significantly increased the body temperature threshold at which Scn1a+/− mice had a generalized tonic–clonic seizure. Both amorfrutin 2 and magnolol significantly decreased the proportion of mice exhibiting hindlimb extension in the MES test. Furthermore, magnolol reduced the number and duration of atypical absence seizures in Gabrb3+/D120N mice. The three compounds inhibited all T‐type calcium channel subtypes but were without specific activity at cannabinoid receptors. Significance We show for the first time that amorfrutin 2 and magnolol display novel antiseizure activity in mouse drug‐resistant epilepsy models. Our results justify future drug discovery campaigns around these structural scaffolds that aim to develop novel antiseizure drugs for intractable epilepsies.

Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1/GluA2

Cannabidiol activates neuronal Kv7 channels

The Potential Mechanism of Cannabidiol (CBD) Treatment of Epilepsy in Pentetrazol (PTZ) Kindling Mice Uncovered by Multi-Omics Analysis

Optimization of Seizure Prevention by Cannabidiol (CBD)

Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model

High Dosage of Cannabidiol (cbd) Alleviates Pentylenetetrazole-Induced Epilepsy in Rats by Exerting an Anticonvulsive Effect

Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy

Cannabichromene from Full-Spectrum Hemp Extract Exerts Acute Anti-Seizure Effects Through Allosteric Activation of GABAA Receptors

Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ9-THC through the 5-HT1A Receptor in the Neocortex of Mice

Cannabidiol Inhibits Nav Channels Through Two Distinct Binding Sites.

A GABA-A receptor response to CBD following status epilepticus in the medial entorhinal cortex of the rat

Altered Glutamate Metabolism Contributes to Antiepileptogenic Effects in the Progression from Focal Seizure to Generalized Seizure by Low-Frequency Stimulation in the Ventral Hippocampus

Inhibitory effects of cannabidiol on voltage-dependent sodium currents

Cannabidiol effect in pentylenetetrazole-induced seizures depends on PI3K

Cannabinoid inhibition of mechanosensitive K+ channels

Cannabinoid Receptor 2 Agonist AM1241 Alleviates Epileptic Seizures and Epilepsy-Associated Depression Via Inhibiting Neuroinflammation in a Pilocarpine-Induced Chronic Epilepsy Mouse Model

Jujuboside B Inhibits Febrile Seizure by Modulating AMPA Receptor Activity.

Multifaceted targets of cannabidiol in epilepsy: Modulating glutamate signaling and beyond

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy

The proposed mechanisms of action of CBD in epilepsy

Cannabinoid‐like compounds found in non‐cannabis plants exhibit antiseizure activity in genetic mouse models of drug‐resistant epilepsy